Skip to main content
MYUNGMOON PHARM CO.,LTD logo

MYUNGMOON PHARM CO.,LTD — Investor Relations & Filings

Ticker · 017180 ISIN · KR7017180001 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2020-02-25 Proxy Solicitation & In…
Country KR South Korea
Listing KO 017180

About MYUNGMOON PHARM CO.,LTD

http://mmpharm.co.kr/en/main/

Myungmoon Pharm Co., Ltd. is a research-based pharmaceutical company engaged in the development, manufacturing, and commercialization of healthcare products. The company produces over 250 specialized and general medicines, holding more than 400 manufacturing licenses. Its portfolio includes both ethical (ETC) and over-the-counter (OTC) drugs, with key product areas in anesthetics, digestive agents, and antitussives. The company's operations encompass the wholesale, import, and export of its pharmaceutical products for domestic and international markets.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Myungmoon Pharm Co., Ltd. It contains the meeting agenda, details on voting procedures, electronic voting instructions, and financial statements (balance sheet, income statement, etc.) to be approved at the meeting. This is a standard proxy solicitation document sent to shareholders to inform them of the upcoming AGM and request their votes, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-02-25 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Myungmoon Pharm. It outlines the date, location, and agenda items (financial statement approval, director/auditor appointments). This type of document is a standard proxy solicitation/notice of meeting, which falls under the Proxy Solicitation & Information Statement category.
2020-02-24 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Management Reports Classification · 95% confidence The document is a regulatory filing from Myungmoon Pharm regarding a significant change in sales or profit/loss structure (30% or more). It provides preliminary financial results (revenue, operating profit, net income) for the fiscal year compared to the previous year. This type of disclosure is a standard regulatory requirement for listed companies to announce preliminary earnings before the final audited report is published. It fits the definition of an Earnings Release (ER) as it provides key financial highlights and the reasons for the change.
2020-02-07 Korean
유상증자결정(종속회사의주요경영사항)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from Myungmoon Pharm regarding a decision to conduct a paid-in capital increase (rights offering) for its subsidiary, Myungmoon Investment Development. It details the number of new shares, issuance price, purpose of funds, and key dates. This falls under the category of share issuance and capital changes.
2019-12-13 Korean
타법인주식및출자증권취득결정
Capital/Financing Update Classification · 98% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a 'Decision to Acquire Shares and Securities of Another Corporation' (타법인주식및출자증권취득결정). It details the acquisition of shares in a subsidiary (Myungmoon Investment Development) by the parent company (Myungmoon Pharm). Since this is a specific regulatory disclosure regarding corporate investment activity and does not fit into categories like M&A (which usually implies external takeovers) or capital changes (share issuance), it is classified as a general Regulatory Filing (RNS).
2019-12-13 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Myungmoon Pharm Co., Ltd. covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial information, business descriptions, capital changes, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.